1 Anderson JW (2003) Whole grains protect against atherosclerotic cardiovascular disease. Proc Nutr Soc 62, 135–142.
2 Jacobs DR, Meyer KA, Kushi LH, et al. (1998) Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr 68, 248–257.
3 Liu SM, Stampfer MJ, Hu FB, et al. (1999) Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 70, 412–419.
4 Liu SM, Manson JE, Stampfer MJ, et al. (2000) Whole grain consumption and risk of ischemic stroke in women – a prospective study. JAMA 284, 1534–1540.
5 McKeown NM, Jacques P & Mayer J (2001) Whole grain intake and risk of ischemic stroke in women. Nutr Rev 59, 149–152.
6 Ajani UA, Ford ES & Mokdad AH (2004) Dietary fiber and C-reactive protein: findings from National Health and Nutrition Examination Survey Data. J Nutr 134, 1181–1185.
7 Pereira MA, Jacobs DR, Kushi LH, et al. (1998) Whole grain consumption, body weight, fat distribution, and insulin in a bi-racial cohort of young adults: The CARDIA Study. Circulation 97, 18.
8 McKeown NM, Meigs JB, Liu SM, et al. (2002) Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 76, 390–398.
12 Truswell AS (2002) Cereal grains and coronary heart disease. Eur J Clin Nutr 56, 1–14.
13 Pereira MA, Jacobs DR, Pins JJ, et al. (2002) Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr 75, 848–855.
14 Andersson A, Tengblad S, Karlstrom B, et al. (2007) Whole-grain foods do not affect insulin sensitivity or markers of lipid peroxidation and inflammation in healthy, moderately overweight subjects. J Nutr 137, 1401–1407.
15 Behall KM, Scholfield DJ & Hallfrisch J (2006) Whole-grain diets reduce blood pressure in mildly hypercholesterolemic men and women. J Am Diet Assoc 106, 1445–1449.
16 Katcher HI, Legro RS, Kunselman AR, et al. (2008) The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr 87, 79–90.
18 Life Sciences Research Office (2008) Whole Grain Intake and Cardiovascular Disease and Whole Grain Intake and Diabetes: A Review. Bethesda, MD: Life Sciences Research Office.
19 Lang R, Thane CW, Bolton-Smith C, et al. (2003) Consumption of whole-grain foods by British adults: findings from further analysis of two national dietary surveys. Public Health Nutr 6, 479–484.
20 Zanchetti A (2003) 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21, 1011–1053.
21 Thane CW, Jones AR, Stephen AM, et al. (2007) Comparative whole-grain intake of British adults in 1986–7 and 2000–1. Br J Nutr 97, 987–992.
22 Jebb SA, Cole TJ, Doman D, et al. (2000) Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr 83, 115–122.
23 Brady LM, Gower BA, Lovegrove SS, et al. (2004) Revised QUICKI provides a strong surrogate estimate of insulin sensitivity when compared with the minimal model. Int J Obes 28, 222–227.
24 Cicero AFG, Nascetti S, Lopez-Sabater MC, et al. (2008) Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related to lipid oxidative damage: The EUROLIVE study. J Am Coll Nutr 27, 314–320.
25 Madsen MB, Jensen AM & Schmidt EB (2007) The effect of a combination of plant sterol-enriched foods in mildly hypercholesterolemic subjects. Clin Nutr 26, 792–798.
26 Jenkins DJA, Kendall CWC, Marchie A, et al. (2005) Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 81, 380–387.
28 Foster-Powell K, Holt SHA & Brand-Miller JC (2002) International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr 76, 5–56.
29 Jenkins DJA, Wesson V, Wolever TMS, et al. (1988) Wholemeal versus wholegrain breads – proportion of whole or cracked grain and the glycemic response. BMJ 297, 958–960.
30 Wesenberg JC, Carter K, Kadatz D, et al. (2000) Evaluation of Dade-Behring, Sigma and Randox homogeneous HDL cholesterol assays on the Dade-Behring Dimension RxL. Clin Chem 46, A94–A94.
31 Nandeesha H, Koner BC, Dorairajan LN, et al. (2006) Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta 370, 89–93.
32 Amsel L, Cybulski R & Wessel B (2001) Performance of a revised triglycerides method on the Dade Behring Dimension® clinical chemistry system. Clin Chem 47, A57–A57.
33 Shimizu S, Tani Y, Yamada H, et al. (1980) Enzymatic determination of serum-free fatty-acids – a colorimetric method. Anal Biochem 107, 193–198.
34 Savoca R, Jaworek B & Huber AR (2006) New ‘plasma referenced’ POCT glucose monitoring systems – are they suitable for glucose monitoring and diagnosis of diabetes? Clin Chim Acta 372, 199–201.
35 Andersen L, Dinesen B, Jorgensen PN, et al. (1993) Enzyme-immunoassay for intact human insulin in serum or plasma. Clin Chem 39, 578–582.
36 Katz A, Nambi SS, Mather K, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85, 2402–2410.
37 Rabasa-Lhoret R, Bastard JP, Jan V, et al. (2003) Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 88, 4917–4923.
38 Register TC, Burdon KP, Lenchik L, et al. (2004) Variability of serum soluble intercellular adhesion molecule-1 measurements attributable to a common polymorphism. Clin Chem 50, 2185–2187.
39 Garton KJ, Gough PJ, Philalay J, et al. (2003) Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-α-converting enzyme (ADAM 17). J Biol Chem 278, 37459–37464.
40 Ruchaud-Sparagano MH, Drost EM, Donnelly SC, et al. (1998) Potential pro-inflammatory effects of soluble E-selectin upon neutrophil function. Eur J Immunol 28, 80–89.
41 Webber D, Radcliffe CM, Royle L, et al. (2006) Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation. FEBS J 273, 3024–3037.
42 Roberts WL, Moulton L, Law TC, et al. (2001) Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 47, 418–425.
43 Wehlin L, Vedin J, Vaage J, et al. (2004) Activation of complement and leukocyte receptors during on- and off pump coronary artery bypass surgery. Eur J Cardiothorac Surg 25, 35–42.
44 Al-Barjas HS, Ariens R, Grant P, et al. (2006) Raised plasma fibrinogen concentration in patients with abdominal aortic aneurysm. Angiology 57, 607–614.
45 Pannekoek H, Veerman H, Lambers H, et al. (1986) Endothelial plasminogen-activator inhibitor (PAI) – a new member of the serpin gene family. EMBO J 5, 2539–2544.